Zobrazeno 1 - 10
of 157
pro vyhledávání: '"L. E. Rutqvist"'
Autor:
M. Baum, A. Hackshaw, J. Houghtona, L. E. Rutqvist, T. Fornander, B. Nordenskjold, A. Nicolucci, R. Sainsburya
Publikováno v:
Опухоли женской репродуктивной системы, Vol 0, Iss 1-2, Pp 34-41 (2014)
The Zoladex In Pre-menopausal Patients (ZIPP) study was designed to determine whether addition of goserelin (‘Zoladex’) and/or tamoxifen to adjuvant therapy (radiotherapy and/or chemotherapy), provided benefit to pre- or peri-menopausal women wit
Externí odkaz:
https://doaj.org/article/577fbe8743f14759a9b7d90ba2965cd7
Autor:
J.F.R. Robertson, S.E. Come, S.E. Jones, L. Beex, M. Kaufmann, A. Makris, J.W.R. Nortier, K. Possinger, L.-E. Rutqvist
Publikováno v:
Opuholi Ženskoj Reproduktivnoj Sistemy, Vol 0, Iss 1, Pp 33-40 (2014)
For many years, tamoxifen has been the _gold standard_ amongst anti-oestrogen therapies for breast cancer. However, the selective aro- matase inhibitors (AIs), anastrozole, letrozole and exemestane, have demonstrated advantages over tamoxifen as firs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::2d7c581d203d54de436ac14702c6884e
https://ojrs.abvpress.ru/ojrs/article/view/335
https://ojrs.abvpress.ru/ojrs/article/view/335
Publikováno v:
Journal of Smoking Cessation. 8:33-44
Introduction: The ability of Swedish snus to serve as a smoking cessation aid has been documented in several observational, population surveys from Scandinavia, but randomised clinical trials provide more reliable information on efficacy. Aims: To pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::574184f86ea7b46edd4c60f8fc2a976a
https://doi.org/10.1017/jsc.2013.10
https://doi.org/10.1017/jsc.2013.10
Publikováno v:
Work. 38:337-346
Objective: The aims of this study were to generate new knowledge about factors predicting return to work (RTW) among women treated for early-stage breast cancer, and about changes in life satisfaction, and coping, and to examine the association betwe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::042c704332a690cb17f70cf58c8c7688
https://doi.org/10.3233/wor-2011-1137
https://doi.org/10.3233/wor-2011-1137
Autor:
Jonas Bergh, Samuel Rotstein, Helena Johansson, Tommy Fornander, Ulla Johansson, L E Rutqvist, Asgerdur Sverrisdottir
Publikováno v:
Cancer Research. 70:S1-5
Background: Ovarian ablation improves survival in premenopausal women with early breast cancer, but the potential added value by luteinizing hormone-releasing hormone agonists (LHRH-a) to tamoxifen, is still not clear. There has been lack of data rep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f52523ae4b8b7658a35d6517ec72129
https://doi.org/10.1158/0008-5472.sabcs10-s1-5
https://doi.org/10.1158/0008-5472.sabcs10-s1-5
Autor:
Aina Johnsson, Mariann Olsson, L E Rutqvist, Kristina Alexanderson, Marjan Vaez, Tommy Fornander
Publikováno v:
Karolinska Institutet
The most common female cancer in Western countries is breast cancer and women diagnosed with this disease are often under 65 years old. With increasing prevalence of survivors it is important to shed light on problems facing these women after diagnos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c755f22beefa0b48f71983787b02b9b
https://doi.org/10.1080/02841860802477899
https://doi.org/10.1080/02841860802477899
Publikováno v:
Acta Oncologica. 48:915-920
Background. Metastatic cancer from an unknown primary tumour (CUP) is a common and heterogeneous clinical entity. In Sweden like in many other countries, the continuum of care for such patients remains to be established. Material and methods. Data on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f1c2a0d08120b8609e93c09c48953fa
https://doi.org/10.1080/02841860902862503
https://doi.org/10.1080/02841860902862503
Publikováno v:
Journal of Clinical Oncology. 22:3694-3699
Purpose To examine the effects on bone mineral density of 2 years of treatment with a luteinizing hormone-releasing hormone (LHRH) agonist alone or in combination with tamoxifen or tamoxifen alone in premenopausal breast cancer. Patients and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a22507b9535480bdad5b216ff20e5856
https://doi.org/10.1200/jco.2004.08.148
https://doi.org/10.1200/jco.2004.08.148
Publikováno v:
British Journal of Surgery. 88:839-843
Background Preoperative radiotherapy improves local control and survival in rectal cancer, but may also increase postoperative morbidity and mortality rates. Establishing selection criteria for preoperative radiotherapy is crucial. The tumour level a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80536bfc6eed5e965fe01cce4bbdddab
https://doi.org/10.1046/j.0007-1323.2001.01789.x
https://doi.org/10.1046/j.0007-1323.2001.01789.x
Publikováno v:
Cancer. 92:896-902
BACKGROUND The Stockholm II trial is a population-based prospective randomized trial on preoperative radiotherapy in rectal carcinoma. METHODS Eligibility criteria were age younger than 80 years and biopsy-proven adenocarcinoma of the rectum judged r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63f8b23cecc6d7b9fe2a490649200a4c
https://doi.org/10.1002/1097-0142(20010815)92:4<896::aid-cncr1398>3.0.co
https://doi.org/10.1002/1097-0142(20010815)92:4<896::aid-cncr1398>3.0.co